RegMed XB 3rd Annual Conference 2025

Preliminary Program

SESSION

Registration and coffee

Opening
Gunther Coppens, Province of Vlaams-Brabant

Vision and ecosystem of RegMed XB 
Conny Helder, Chair of the Supervisory Board Bernard Mulder, General Director

RegMed XB Pilot Factory
Dominique de Jong, Business developer

Eat & Meet

Patient Testimonial: Tuğrul Irmak

Clinician's Perspective: Coming soon

KEYNOTE: Providing a fully automated process backbone for AI-driven organoid-based tissue manufacturing: living implants 4.0
Ioannis Papantoniou, Associate Prof. KU Leuven

Break

Eye Moonshot as a Case Study for Collaboration
An Van Den Bulcke, Business developer UGent

KEYNOTE: Status of the Regenerative Medicine field from an industrial perspective
Bob Smith, Venture Partner/Chairman, Alliance for Regenerative Medicine (ARM)

Financing landscape for ATMP's
Jan De Kerpel, Managing Director Investment Banking at Van Lanschot Kempen

Panel Discussion: Translating Regenerative Medicine innovations in a changing world. 

Closing
Bart Geers, Chair RegMed XB Flanders

Break - Changing Venues

Reception and Walking diner with Belgian beer pairing at Brewery ' de Hoorn' 

SESSION

Registration and coffee

Opening: Integration of Innovative treatments such as cell and gene therapy into the Healthcare system
Coming soon

Role of academic partners/public domain in the development of ATMP's
Frank Hulstaert, Senior Researcher Federal Healthcare Knowledge Centre (KCE)

KEYNOTE: Developing advanced medicines for the future in an evolving regulatory framework: stakeholder roles and interactions
Ana Hidalgo-Simon, Associate Prof. working on development, translation and access to patients of advanced therapy medicinal products, LUMC

Case study TIL therapy
Inge Jedema, Head of Translational Cellular Therapy, Netherlands Cancer Institute/Antoni van Leeuwenhoek

Break

Overview Translational landscape Flanders 
Bart Geers, Investment Manager KU Leuven

Stimulating public-private partnerships - Health~Holland
Ernst Nagel, Operations Director Health~Holland

Panel Discussion: International translation research from bench to bedside

Eat & Meet

Translational results from disease models
Christine L. Mummery, Prof. Developmental Biology, Leiden University Medical Center (LUMC)

Commercial viability of Cell Therapies - the role of iPSC
Stefan Braam, Startup Incubation Lead, UtrechtInc

On the way to the Moon!
Aart van Apeldoorn, Assistant Prof at: MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, the Netherlands

Eelco de Koning, Professor of Diabetology, Leiden University Medical Center (LUMC)

Closing
Bernard Mulder, General Director RegMed XB

Networking & drinks